Annual CFI
N/A
September 30, 2024
Summary
- OTLK annual cash flow from investing activities is not available.
Performance
OTLK Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
N/A
September 1, 2024
Summary
- OTLK quarterly cash flow from investing activities is not available.
Performance
OTLK Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
N/A
September 1, 2024
Summary
- OTLK TTM cash flow from investing activities is not available.
Performance
OTLK TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
OTLK Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
OTLK Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Outlook Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | -$900.00 K(+105.8%) | $0.00(-100.0%) | -$900.00 K(0.0%) |
| Jun 2020 | - | -$900.00 K(<-9900.0%) | -$900.00 K(+105.9%) |
| Sep 2019 | -$437.30 K(-84.3%) | $0.00(-100.0%) | -$437.20 K(-74.3%) |
| Jun 2019 | - | -$150.70 K(+200.8%) | -$1.70 M(-1.0%) |
| Mar 2019 | - | -$50.10 K(-78.8%) | -$1.72 M(-11.6%) |
| Dec 2018 | - | -$236.40 K(-81.3%) | -$1.94 M(-30.2%) |
| Sep 2018 | -$2.78 M(+852.1%) | -$1.26 M(+651.7%) | -$2.78 M(+80.3%) |
| Jun 2018 | - | -$168.00 K(-39.0%) | -$1.54 M(+6.3%) |
| Mar 2018 | - | -$275.20 K(-74.4%) | -$1.45 M(+19.0%) |
| Dec 2017 | - | -$1.08 M(+4379.6%) | -$1.22 M(+317.3%) |
| Sep 2017 | -$292.10 K | -$24.00 K(-68.5%) | -$292.10 K(-51.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | -$76.20 K(+75.2%) | -$596.50 K(-38.7%) |
| Mar 2017 | - | -$43.50 K(-70.7%) | -$972.80 K(+10.2%) |
| Dec 2016 | - | -$148.40 K(-54.8%) | -$882.40 K(-19.7%) |
| Sep 2016 | -$1.10 M(-87.5%) | -$328.40 K(-27.4%) | -$1.10 M(-73.0%) |
| Jun 2016 | - | -$452.50 K(-1064.8%) | -$4.06 M(-42.8%) |
| Mar 2016 | - | $46.90 K(-112.9%) | -$7.10 M(-17.8%) |
| Dec 2015 | - | -$364.20 K(-88.9%) | -$8.64 M(-1.9%) |
| Sep 2015 | -$8.80 M(+272.0%) | -$3.29 M(-5.6%) | -$8.80 M(+59.8%) |
| Jun 2015 | - | -$3.49 M(+133.8%) | -$5.51 M(+172.7%) |
| Mar 2015 | - | -$1.49 M(+182.8%) | -$2.02 M(+282.8%) |
| Dec 2014 | - | -$527.90 K | -$527.90 K |
| Sep 2014 | -$2.37 M | - | - |
FAQ
- What is the all time high annual CFI for Outlook Therapeutics?
- What is the all time high quarterly CFI for Outlook Therapeutics?
- What is the all time high TTM CFI for Outlook Therapeutics?
What is the all time high annual CFI for Outlook Therapeutics?
Outlook Therapeutics all-time high annual cash flow from investing activities is -$292.10 K
What is the all time high quarterly CFI for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly cash flow from investing activities is $46.90 K
What is the all time high TTM CFI for Outlook Therapeutics?
Outlook Therapeutics all-time high TTM cash flow from investing activities is -$292.10 K